Landscape studies done by yours truly using Foundation - our scientific discovery engine.
According to a recent article in Hepatology, the Journal of the American Association of Liver Diseases, “The scale of the non‐alcoholic fatty liver disease (NAFLD) epidemic is staggering. It is estimated that 24 percent of the world’s people have NAFLD. By the year 2030, the United States will have approximately 100 million individuals with NAFLD leading to a higher incidence of decompensated cirrhosis, hepatocellular carcinoma (HCC), and liver-related death.”
The Resolute Research Report presents data on recent developments in identification of biomarkers in the area of NAFLD.
In 2020, the size of the global molecular diagnostics market was $36.2 billion, according to this April 2021 report from Grand View Research. What is driving the growth of the market?
This Resolute Research report highlights activity in the molecular diagnostics market over the past five years (July 1, 2016, to July 1, 2021).
A July 2021 market research report valued the gene therapy market at US$524 million in 2018 with a compound annual growth rate of 40.7% by 2025. This growing market is a hotbed of activity in numerous areas, and many new companies have sprung up to capture this market in the past year.
This Resolute Research Report highlights recent activity in gene therapy over the last year (July 1, 2020-July 1, 2021).